Focus:
Astellas Pharma unveiled its plans to construct an active pharmaceutical ingredient (API) manufacturing facility in Toyama, Japan, in January 2020.
Astellas Pharma unveiled its plans to construct an active pharmaceutical ingredient (API) manufacturing facility in...
Read More...
Phillips-Medisize is expanding its existing global innovation and development (GID) centre in Struer, Denmark.
Read More...
Merck, a pharmaceutical company based in Germany, is building a biotech development facility in Corsier-sur-Vevey,...
Read More...
Hitachi Chemical Advanced Therapeutics Solutions (HCATS) opened its new manufacturing facility in New Jersey, US,...
Read More...
Eli Lilly and Company is planning to build a new pharmaceutical manufacturing facility in Durham...
Read More...
GE Healthcare is building a manufacturing facility for cell processing kits in Grens, Switzerland.
Read More...
STA Pharmaceutical (STA), a subsidiary of WuXi AppTec, opened its new large-scale oligonucleotide active pharmaceutical...
Read More...
GE Healthcare (GEHC) Life Sciences and the University of Massachusetts Medical School (UMMS) unveiled plans...
Read More...
Rentschler Biopharma is carrying out an expansion of its recently acquired biopharmaceutical manufacturing facility located...
Read More...
Novartis opened its new cell and gene therapy facility in Stein, Switzerland, in November 2019....
Read More...
